Global Personalized Medicines In Oncology Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 07-Apr-2021
No. of pages: 105
Inquire Before Buying

Global Personalized Medicines In Oncology Scope and Market Size

Personalized Medicines In Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Medicines In Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Molecular Oncopathology

- Genome Diagnostics

- Radiation Therapy

- Oncology Testing

- Chemotherapy

- Others

Segment by Application

- Research Centers

- Governmental Institutions

- Hospitals

- Clinical Centers

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Biotheranostics

- Illumina

- DNA Link

- Genomic Health, Inc.(Exact Sciences)

- Cypher Genomics(Human Longevity, Inc.)

- Life Technologies Corporation(Thermo Fisher Scientific)

- Fulgent Genetics

- Caris Life Sciences

- Ariana Pharma

- Abbott Laboratories

- deCODE genetics

- Exagen Inc

Global Personalized Medicines In Oncology Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines In Oncology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Molecular Oncopathology
1.2.3 Genome Diagnostics
1.2.4 Radiation Therapy
1.2.5 Oncology Testing
1.2.6 Chemotherapy
1.2.7 Others
1.3 Market by Application
1.3.1 Global Personalized Medicines In Oncology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research Centers
1.3.3 Governmental Institutions
1.3.4 Hospitals
1.3.5 Clinical Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicines In Oncology Market Perspective (2016-2027)
2.2 Personalized Medicines In Oncology Growth Trends by Regions
2.2.1 Personalized Medicines In Oncology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Personalized Medicines In Oncology Historic Market Share by Regions (2016-2021)
2.2.3 Personalized Medicines In Oncology Forecasted Market Size by Regions (2022-2027)
2.3 Personalized Medicines In Oncology Industry Dynamic
2.3.1 Personalized Medicines In Oncology Market Trends
2.3.2 Personalized Medicines In Oncology Market Drivers
2.3.3 Personalized Medicines In Oncology Market Challenges
2.3.4 Personalized Medicines In Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicines In Oncology Players by Revenue
3.1.1 Global Top Personalized Medicines In Oncology Players by Revenue (2016-2021)
3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2016-2021)
3.2 Global Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicines In Oncology Revenue
3.4 Global Personalized Medicines In Oncology Market Concentration Ratio
3.4.1 Global Personalized Medicines In Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines In Oncology Revenue in 2020
3.5 Personalized Medicines In Oncology Key Players Head office and Area Served
3.6 Key Players Personalized Medicines In Oncology Product Solution and Service
3.7 Date of Enter into Personalized Medicines In Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicines In Oncology Breakdown Data by Type
4.1 Global Personalized Medicines In Oncology Historic Market Size by Type (2016-2021)
4.2 Global Personalized Medicines In Oncology Forecasted Market Size by Type (2022-2027)
5 Personalized Medicines In Oncology Breakdown Data by Application
5.1 Global Personalized Medicines In Oncology Historic Market Size by Application (2016-2021)
5.2 Global Personalized Medicines In Oncology Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Personalized Medicines In Oncology Market Size (2016-2027)
6.2 North America Personalized Medicines In Oncology Market Size by Type
6.2.1 North America Personalized Medicines In Oncology Market Size by Type (2016-2021)
6.2.2 North America Personalized Medicines In Oncology Market Size by Type (2022-2027)
6.2.3 North America Personalized Medicines In Oncology Market Size by Type (2016-2027)
6.3 North America Personalized Medicines In Oncology Market Size by Application
6.3.1 North America Personalized Medicines In Oncology Market Size by Application (2016-2021)
6.3.2 North America Personalized Medicines In Oncology Market Size by Application (2022-2027)
6.3.3 North America Personalized Medicines In Oncology Market Size by Application (2016-2027)
6.4 North America Personalized Medicines In Oncology Market Size by Country
6.4.1 North America Personalized Medicines In Oncology Market Size by Country (2016-2021)
6.4.2 North America Personalized Medicines In Oncology Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Personalized Medicines In Oncology Market Size (2016-2027)
7.2 Europe Personalized Medicines In Oncology Market Size by Type
7.2.1 Europe Personalized Medicines In Oncology Market Size by Type (2016-2021)
7.2.2 Europe Personalized Medicines In Oncology Market Size by Type (2022-2027)
7.2.3 Europe Personalized Medicines In Oncology Market Size by Type (2016-2027)
7.3 Europe Personalized Medicines In Oncology Market Size by Application
7.3.1 Europe Personalized Medicines In Oncology Market Size by Application (2016-2021)
7.3.2 Europe Personalized Medicines In Oncology Market Size by Application (2022-2027)
7.3.3 Europe Personalized Medicines In Oncology Market Size by Application (2016-2027)
7.4 Europe Personalized Medicines In Oncology Market Size by Country
7.4.1 Europe Personalized Medicines In Oncology Market Size by Country (2016-2021)
7.4.2 Europe Personalized Medicines In Oncology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines In Oncology Market Size (2016-2027)
8.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Type
8.2.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2016-2027)
8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Application
8.3.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2016-2027)
8.4 Asia-Pacific Personalized Medicines In Oncology Market Size by Region
8.4.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Personalized Medicines In Oncology Market Size (2016-2027)
9.2 Latin America Personalized Medicines In Oncology Market Size by Type
9.2.1 Latin America Personalized Medicines In Oncology Market Size by Type (2016-2021)
9.2.2 Latin America Personalized Medicines In Oncology Market Size by Type (2022-2027)
9.2.3 Latin America Personalized Medicines In Oncology Market Size by Type (2016-2027)
9.3 Latin America Personalized Medicines In Oncology Market Size by Application
9.3.1 Latin America Personalized Medicines In Oncology Market Size by Application (2016-2021)
9.3.2 Latin America Personalized Medicines In Oncology Market Size by Application (2022-2027)
9.3.3 Latin America Personalized Medicines In Oncology Market Size by Application (2016-2027)
9.4 Latin America Personalized Medicines In Oncology Market Size by Country
9.4.1 Latin America Personalized Medicines In Oncology Market Size by Country (2016-2021)
9.4.2 Latin America Personalized Medicines In Oncology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines In Oncology Market Size (2016-2027)
10.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Type
10.2.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2016-2027)
10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Application
10.3.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2016-2027)
10.4 Middle East & Africa Personalized Medicines In Oncology Market Size by Country
10.4.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biotheranostics
11.1.1 Biotheranostics Company Details
11.1.2 Biotheranostics Business Overview
11.1.3 Biotheranostics Personalized Medicines In Oncology Introduction
11.1.4 Biotheranostics Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.1.5 Biotheranostics Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Personalized Medicines In Oncology Introduction
11.2.4 Illumina Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.2.5 Illumina Recent Development
11.3 DNA Link
11.3.1 DNA Link Company Details
11.3.2 DNA Link Business Overview
11.3.3 DNA Link Personalized Medicines In Oncology Introduction
11.3.4 DNA Link Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.3.5 DNA Link Recent Development
11.4 Genomic Health, Inc.(Exact Sciences)
11.4.1 Genomic Health, Inc.(Exact Sciences) Company Details
11.4.2 Genomic Health, Inc.(Exact Sciences) Business Overview
11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Introduction
11.4.4 Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.4.5 Genomic Health, Inc.(Exact Sciences) Recent Development
11.5 Cypher Genomics(Human Longevity, Inc.)
11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Details
11.5.2 Cypher Genomics(Human Longevity, Inc.) Business Overview
11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Introduction
11.5.4 Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Development
11.6 Life Technologies Corporation(Thermo Fisher Scientific)
11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Details
11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Introduction
11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Details
11.7.2 Fulgent Genetics Business Overview
11.7.3 Fulgent Genetics Personalized Medicines In Oncology Introduction
11.7.4 Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.7.5 Fulgent Genetics Recent Development
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Details
11.8.2 Caris Life Sciences Business Overview
11.8.3 Caris Life Sciences Personalized Medicines In Oncology Introduction
11.8.4 Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.8.5 Caris Life Sciences Recent Development
11.9 Ariana Pharma
11.9.1 Ariana Pharma Company Details
11.9.2 Ariana Pharma Business Overview
11.9.3 Ariana Pharma Personalized Medicines In Oncology Introduction
11.9.4 Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.9.5 Ariana Pharma Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Personalized Medicines In Oncology Introduction
11.10.4 Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.10.5 Abbott Laboratories Recent Development
11.11 deCODE genetics
11.11.1 deCODE genetics Company Details
11.11.2 deCODE genetics Business Overview
11.11.3 deCODE genetics Personalized Medicines In Oncology Introduction
11.11.4 deCODE genetics Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.11.5 deCODE genetics Recent Development
11.12 Exagen Inc
11.12.1 Exagen Inc Company Details
11.12.2 Exagen Inc Business Overview
11.12.3 Exagen Inc Personalized Medicines In Oncology Introduction
11.12.4 Exagen Inc Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.12.5 Exagen Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Personalized Medicines In Oncology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Molecular Oncopathology
Table 3. Key Players of Genome Diagnostics
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Oncology Testing
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Others
Table 8. Global Personalized Medicines In Oncology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Personalized Medicines In Oncology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Personalized Medicines In Oncology Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Personalized Medicines In Oncology Market Share by Regions (2016-2021)
Table 12. Global Personalized Medicines In Oncology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Personalized Medicines In Oncology Market Share by Regions (2022-2027)
Table 14. Personalized Medicines In Oncology Market Trends
Table 15. Personalized Medicines In Oncology Market Drivers
Table 16. Personalized Medicines In Oncology Market Challenges
Table 17. Personalized Medicines In Oncology Market Restraints
Table 18. Global Personalized Medicines In Oncology Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Personalized Medicines In Oncology Market Share by Players (2016-2021)
Table 20. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicines In Oncology as of 2020)
Table 21. Ranking of Global Top Personalized Medicines In Oncology Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Personalized Medicines In Oncology Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Personalized Medicines In Oncology Product Solution and Service
Table 25. Date of Enter into Personalized Medicines In Oncology Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Personalized Medicines In Oncology Revenue Market Share by Type (2016-2021)
Table 29. Global Personalized Medicines In Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Personalized Medicines In Oncology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Personalized Medicines In Oncology Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Personalized Medicines In Oncology Revenue Market Share by Application (2016-2021)
Table 33. Global Personalized Medicines In Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Personalized Medicines In Oncology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Personalized Medicines In Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Personalized Medicines In Oncology Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Personalized Medicines In Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Personalized Medicines In Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Personalized Medicines In Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Personalized Medicines In Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Personalized Medicines In Oncology Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Personalized Medicines In Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Personalized Medicines In Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Personalized Medicines In Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Personalized Medicines In Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Personalized Medicines In Oncology Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Personalized Medicines In Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Personalized Medicines In Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Personalized Medicines In Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 65. Biotheranostics Company Details
Table 66. Biotheranostics Business Overview
Table 67. Biotheranostics Personalized Medicines In Oncology Product
Table 68. Biotheranostics Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 69. Biotheranostics Recent Development
Table 70. Illumina Company Details
Table 71. Illumina Business Overview
Table 72. Illumina Personalized Medicines In Oncology Product
Table 73. Illumina Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 74. Illumina Recent Development
Table 75. DNA Link Company Details
Table 76. DNA Link Business Overview
Table 77. DNA Link Personalized Medicines In Oncology Product
Table 78. DNA Link Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 79. DNA Link Recent Development
Table 80. Genomic Health, Inc.(Exact Sciences) Company Details
Table 81. Genomic Health, Inc.(Exact Sciences) Business Overview
Table 82. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product
Table 83. Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 84. Genomic Health, Inc.(Exact Sciences) Recent Development
Table 85. Cypher Genomics(Human Longevity, Inc.) Company Details
Table 86. Cypher Genomics(Human Longevity, Inc.) Business Overview
Table 87. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product
Table 88. Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 89. Cypher Genomics(Human Longevity, Inc.) Recent Development
Table 90. Life Technologies Corporation(Thermo Fisher Scientific) Company Details
Table 91. Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
Table 92. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product
Table 93. Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 94. Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
Table 95. Fulgent Genetics Company Details
Table 96. Fulgent Genetics Business Overview
Table 97. Fulgent Genetics Personalized Medicines In Oncology Product
Table 98. Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 99. Fulgent Genetics Recent Development
Table 100. Caris Life Sciences Company Details
Table 101. Caris Life Sciences Business Overview
Table 102. Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 103. Caris Life Sciences Recent Development
Table 104. Ariana Pharma Company Details
Table 105. Ariana Pharma Business Overview
Table 106. Ariana Pharma Personalized Medicines In Oncology Product
Table 107. Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 108. Ariana Pharma Recent Development
Table 109. Abbott Laboratories Company Details
Table 110. Abbott Laboratories Business Overview
Table 111. Abbott Laboratories Personalized Medicines In Oncology Product
Table 112. Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 113. Abbott Laboratories Recent Development
Table 114. deCODE genetics Company Details
Table 115. deCODE genetics Business Overview
Table 116. deCODE genetics Personalized Medicines In Oncology Product
Table 117. deCODE genetics Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 118. deCODE genetics Recent Development
Table 119. Exagen Inc Company Details
Table 120. Exagen Inc Business Overview
Table 121. Exagen Inc Personalized Medicines In Oncology Product
Table 122. Exagen Inc Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 123. Exagen Inc Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Medicines In Oncology Market Share by Type: 2020 VS 2027
Figure 2. Molecular Oncopathology Features
Figure 3. Genome Diagnostics Features
Figure 4. Radiation Therapy Features
Figure 5. Oncology Testing Features
Figure 6. Chemotherapy Features
Figure 7. Others Features
Figure 8. Global Personalized Medicines In Oncology Market Share by Application: 2020 VS 2027
Figure 9. Research Centers Case Studies
Figure 10. Governmental Institutions Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Clinical Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Personalized Medicines In Oncology Report Years Considered
Figure 15. Global Personalized Medicines In Oncology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Personalized Medicines In Oncology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Personalized Medicines In Oncology Market Share by Regions: 2020 VS 2027
Figure 18. Global Personalized Medicines In Oncology Market Share by Regions (2022-2027)
Figure 19. Global Personalized Medicines In Oncology Market Share by Players in 2020
Figure 20. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicines In Oncology as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Personalized Medicines In Oncology Revenue in 2020
Figure 22. Global Personalized Medicines In Oncology Revenue Market Share by Type (2016-2021)
Figure 23. Global Personalized Medicines In Oncology Revenue Market Share by Type (2022-2027)
Figure 24. North America Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Personalized Medicines In Oncology Market Share by Type (2016-2027)
Figure 26. North America Personalized Medicines In Oncology Market Share by Application (2016-2027)
Figure 27. North America Personalized Medicines In Oncology Market Share by Country (2016-2027)
Figure 28. United States Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Personalized Medicines In Oncology Market Share by Type (2016-2027)
Figure 32. Europe Personalized Medicines In Oncology Market Share by Application (2016-2027)
Figure 33. Europe Personalized Medicines In Oncology Market Share by Country (2016-2027)
Figure 34. Germany Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Personalized Medicines In Oncology Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Personalized Medicines In Oncology Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Personalized Medicines In Oncology Market Share by Region (2016-2027)
Figure 44. China Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Personalized Medicines In Oncology Market Share by Type (2016-2027)
Figure 52. Latin America Personalized Medicines In Oncology Market Share by Application (2016-2027)
Figure 53. Latin America Personalized Medicines In Oncology Market Share by Country (2016-2027)
Figure 54. Mexico Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Personalized Medicines In Oncology Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Personalized Medicines In Oncology Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Personalized Medicines In Oncology Market Share by Country (2016-2027)
Figure 60. Turkey Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Biotheranostics Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 64. Illumina Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 65. DNA Link Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 66. Genomic Health, Inc.(Exact Sciences) Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 67. Cypher Genomics(Human Longevity, Inc.) Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 68. Life Technologies Corporation(Thermo Fisher Scientific) Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 69. Fulgent Genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 70. Caris Life Sciences Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 71. Ariana Pharma Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 72. Abbott Laboratories Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 73. deCODE genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 74. Exagen Inc Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • (Post-pandemic Era) - Global Yervoy Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 89
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Yervoy growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is......
  • (Post-pandemic Era) - Global Yervoy Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 100
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Yervoy Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 103
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global X-ray Tubes Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 85
    Summary This study analysis was given on a worldwide scale, for instance, present and historical X-ray Tubes growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regio......
  • (Post-pandemic Era) - Global X-ray Tubes Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 105
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global X-ray Tubes Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 100
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Women's Health Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 94
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Women's Health growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related re......
  • (Post-pandemic Era) - Global Women's Health Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 119
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Women's Health Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 110
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs